Helicobacter pylori

Why it still matters in 2005

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Despite falling prevalence rates in the developed world, H pylori is still present in the United States and is particularly prevalent among racial minorities and recent immigrants. H pylori infection is clearly associated with an increased risk of peptic ulcer disease, gastric cancer, and MALT lymphoma, and it is associated with some cases of uninvestigated dyspepsia. Identification and eradication of H pylori improves outcomes in patients with peptic ulcer disease and causes tumor regression in patients with MALT lymphoma. It is uncertain whether H pylori eradication will improve outcomes in patients with gastric cancer. Decision analytic models suggest that a test-and-treat strategy for H pylori is rational and cost-effective for patients with uninvestigated dyspepsia.

Original languageEnglish (US)
JournalCleveland Clinic Journal of Medicine
Volume72
Issue numberSUPPL.2
DOIs
StatePublished - 2004

Fingerprint

Pylorus
Helicobacter pylori
Marginal Zone B-Cell Lymphoma
Dyspepsia
Peptic Ulcer
Stomach Neoplasms
Accidental Falls
Costs and Cost Analysis
Infection
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Helicobacter pylori : Why it still matters in 2005. / Fennerty, M (Brian).

In: Cleveland Clinic Journal of Medicine, Vol. 72, No. SUPPL.2, 2004.

Research output: Contribution to journalArticle

@article{33a270092123404a87846276368d0c78,
title = "Helicobacter pylori: Why it still matters in 2005",
abstract = "Despite falling prevalence rates in the developed world, H pylori is still present in the United States and is particularly prevalent among racial minorities and recent immigrants. H pylori infection is clearly associated with an increased risk of peptic ulcer disease, gastric cancer, and MALT lymphoma, and it is associated with some cases of uninvestigated dyspepsia. Identification and eradication of H pylori improves outcomes in patients with peptic ulcer disease and causes tumor regression in patients with MALT lymphoma. It is uncertain whether H pylori eradication will improve outcomes in patients with gastric cancer. Decision analytic models suggest that a test-and-treat strategy for H pylori is rational and cost-effective for patients with uninvestigated dyspepsia.",
author = "Fennerty, {M (Brian)}",
year = "2004",
doi = "10.3949/ccjm.72.Suppl_2.S1",
language = "English (US)",
volume = "72",
journal = "Cleveland Clinic Journal of Medicine",
issn = "0891-1150",
publisher = "Cleveland Clinic Educational Foundation",
number = "SUPPL.2",

}

TY - JOUR

T1 - Helicobacter pylori

T2 - Why it still matters in 2005

AU - Fennerty, M (Brian)

PY - 2004

Y1 - 2004

N2 - Despite falling prevalence rates in the developed world, H pylori is still present in the United States and is particularly prevalent among racial minorities and recent immigrants. H pylori infection is clearly associated with an increased risk of peptic ulcer disease, gastric cancer, and MALT lymphoma, and it is associated with some cases of uninvestigated dyspepsia. Identification and eradication of H pylori improves outcomes in patients with peptic ulcer disease and causes tumor regression in patients with MALT lymphoma. It is uncertain whether H pylori eradication will improve outcomes in patients with gastric cancer. Decision analytic models suggest that a test-and-treat strategy for H pylori is rational and cost-effective for patients with uninvestigated dyspepsia.

AB - Despite falling prevalence rates in the developed world, H pylori is still present in the United States and is particularly prevalent among racial minorities and recent immigrants. H pylori infection is clearly associated with an increased risk of peptic ulcer disease, gastric cancer, and MALT lymphoma, and it is associated with some cases of uninvestigated dyspepsia. Identification and eradication of H pylori improves outcomes in patients with peptic ulcer disease and causes tumor regression in patients with MALT lymphoma. It is uncertain whether H pylori eradication will improve outcomes in patients with gastric cancer. Decision analytic models suggest that a test-and-treat strategy for H pylori is rational and cost-effective for patients with uninvestigated dyspepsia.

UR - http://www.scopus.com/inward/record.url?scp=84884552458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884552458&partnerID=8YFLogxK

U2 - 10.3949/ccjm.72.Suppl_2.S1

DO - 10.3949/ccjm.72.Suppl_2.S1

M3 - Article

VL - 72

JO - Cleveland Clinic Journal of Medicine

JF - Cleveland Clinic Journal of Medicine

SN - 0891-1150

IS - SUPPL.2

ER -